GHK-Cu has passed the screen but not yet faced the exam
Plattner F, Angelo M, Giese KP
Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis
Walker RL, Cottingham MD, Fisher JA
Proper use is key for seeing results : To get the full benefits, apply GHK-Cu serums separately from potent ingredients like retinoids and vitamin C, and consult with a professional to develop a safe and personalized peptide therapy plan
For instance, a review we conducted at this time of ClinicalTrials.gov.org using NAD + as other term input and the following precursors as intervention reveals that there are 4 clinical trials investigating NA, 7 trials focused on NAM, 8 trials administering NAD + , 16 trials studying NMN, and over 60 trials exploring NR with NAD + measurements included as readout